Company Information

SHILPA MEDICARE LTD.

NSE : SHILPAMEDBSE : 530549ISIN CODE : INE790G01031Industry : Pharmaceuticals & DrugsHouse : Private
BSE531.15-4 (-0.75 %)
PREV CLOSE ( ) 535.15
OPEN PRICE ( ) 536.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 33635
TODAY'S LOW / HIGH ( )528.20 542.00
52 WK LOW / HIGH ( )228.25 558
NSE531.10-3.9 (-0.73 %)
PREV CLOSE( ) 535.00
OPEN PRICE ( ) 538.00
BID PRICE (QTY) 531.10 (199)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 241892
TODAY'S LOW / HIGH( ) 529.10 542.40
52 WK LOW / HIGH ( )228.5 557.7
ChairmanOmprakash Inani
Managing DirectorVishnukant Bhutada
Company SecretaryRitu Tiwary
Non Executive Independent DirectorHetal Madhukant Gandhi
Arvind Vasudeva
Kamal K Sharma
Anita Bandyopadhyay
Whole Time DirectorSharath Reddy Kalakota
Incorporation Year : 1987

Registered Office :

Address : Shilpa House,#12-6-214/ A1,Hyderabad Road Raichur,
Karnataka-584135 .

Phone : 08532-238704

Email :  info@vbshilpa.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.